101 participants
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-31
- Start Date:
- 2025-08-27
- Completion:
- 2027-08-01
Conditions
- Peripheral T Cell Lymphoma
Interventions
- DRUG
No Results Yet